DGX

Companies
Nyse American
Quest Diagnostics Inc.
Health Care
Price Chart
Overview

About DGX

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Market Cap
$15.8B
Volume
214.4M
Avg. Volume
227.0M
P/E Ratio
16.741802
Dividend Yield
2.00%
Employees
36.5K

Company Information

Exchange
Nyse American
Sector
Health Care
Industry
Diagnostics & Research
Risk & Correlation Analysis
Market Correlation
0.42
Low Correlation
Volatility
Medium (0.21)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Low Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for DGX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, DGX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$15.8B
Volume214.4M
P/E Ratio16.74
Dividend Yield2.00%
Important Dates
Next Dividend
April 21, 2025
Next Earnings
April 21, 2025

PortfolioPilot Analysis

Get AI-powered insights on how DGX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025